Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pregnancy and Postpartum CGM in GDM
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.
Official title: Pregnancy and Postpartum Continuous Glucose Monitoring in Gestational Diabetes
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-08-05
Completion Date
2026-08-15
Last Updated
2025-09-15
Healthy Volunteers
No
Conditions
Interventions
continuous glucose monitor
All participants who wear CGM
Locations (1)
Icahn School of Medicine at Mount Sinai
New York, New York, United States